We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A controversial new packaging decree issued by Brazilian regulator Anvisa -- which was due to come into effect in May -- is now likely to be delayed, according to local reports.
A team of private sector scientists based in Scotland has announced a breakthrough in stem cell research, with potentially significant implications for the treatment of Alzheimer's and Parkinson's disease.
Leading Indian generics makers Ranbaxy and Lupin are to enter the Japanese market through product tie-ups with local manufacturers, indicating that the potentially lucrative market retains significant entry barriers.
Stellar Pharmaceuticals Inc. ("Stellar") (TSX VENTURE:SLX)(OTCBB:SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today reported signing a Licensing Agreement with TECHNIMED of Anteljas, Lebanon in respect of the distribution and sale of NeoVisc(R), a product used for the treatment of osteoarthritis, in Lebanon and Syria.
Idenix Pharmaceuticals Inc. (IDIX.O: Quote, Profile, Research) may periodically sell up to $150 million in common stock while existing shareholders may offer shares worth an additional $20 million, according to a regulatory filing on Friday.
Bavarian Nordic A/S announced today that it has filed a patent infringement action against Acambis plc's MVA smallpox vaccine products at the U.S. International Trade Commission based in Washington DC. If successful, Bavarian Nordic will be in a position to either stop Acambis from engaging in the importation of any infringing MVA smallpox vaccine products into the USA, or seek a royalty for each infringing dose of MVA smallpox vaccine imported to the USA.
Predictive medicine company IMI International Medical Innovations Inc. (TSX: IMI; Amex: IME) (the "Company" or "IMI") today announced it has entered into an engagement letter for a bought-deal private placement financing with a syndicate of underwriters led by Orion Securities Inc. and including Loewen Ondaatje McCutcheon Limited to issue CDN$10,000,000 (US$8,210,000) of units (the "Units") of the Company.
Official statistics indicate that manufacturer prices for pharmaceuticals produced in South Africa rose 0.7% in June 2005, compared to the previous month.